BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33309417)

  • 1. Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.
    Collins A; Miles GJ; Powley IR; Hew R; Pringle JH; MacFarlane M; Pritchard C; Moss EL
    Gynecol Oncol; 2021 Feb; 160(2):557-567. PubMed ID: 33309417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
    Cassier PA; Navaridas R; Bellina M; Rama N; Ducarouge B; Hernandez-Vargas H; Delord JP; Lengrand J; Paradisi A; Fattet L; Garin G; Gheit H; Dalban C; Pastushenko I; Neves D; Jelin R; Gadot N; Braissand N; Léon S; Degletagne C; Matias-Guiu X; Devouassoux-Shisheboran M; Mery-Lamarche E; Allard J; Zindy E; Decaestecker C; Salmon I; Perol D; Dolcet X; Ray-Coquard I; Blanpain C; Bernet A; Mehlen P
    Nature; 2023 Aug; 620(7973):409-416. PubMed ID: 37532934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a long term, ex vivo, patient-derived explant model of endometrial cancer.
    van der Woude H; Phan K; Kenwright DN; Goossens L; Hally KE; Currie MJ; Kokkinos J; Sharbeen G; Phillips PA; Henry CE
    PLoS One; 2024; 19(4):e0301413. PubMed ID: 38635728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
    Powley IR; Patel M; Miles G; Pringle H; Howells L; Thomas A; Kettleborough C; Bryans J; Hammonds T; MacFarlane M; Pritchard C
    Br J Cancer; 2020 Mar; 122(6):735-744. PubMed ID: 31894140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures.
    Abreu S; Silva F; Mendes R; Mendes TF; Teixeira M; Santo VE; Boghaert ER; Félix A; Brito C
    Sci Rep; 2020 Nov; 10(1):19462. PubMed ID: 33173111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.
    Kudlowitz D; Velastegui A; Musa F; Muggia F
    Cancer Chemother Pharmacol; 2018 May; 81(5):847-851. PubMed ID: 29516152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
    Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A
    Gynecol Oncol; 2020 Dec; 159(3):721-731. PubMed ID: 32988624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
    Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
    Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology).
    Mustea A; Koensgen D; Belau A; Sehouli J; Lichtenegger W; Schneidewind L; Sommer H; Markmann S; Scharf JP; Ehmke M; Ledwon P; Braicu I; Zygmunt M; Koehler G
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):975-83. PubMed ID: 23995698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy After Immunotherapy: Response Rescue in a Patient With Microsatellite Instability-high Colorectal Cancer Post-Pembrolizumab.
    Das S; Allen A; Berlin J
    Clin Colorectal Cancer; 2020 Jun; 19(2):137-140. PubMed ID: 32146081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.
    Collins A; Miles GJ; Wood J; MacFarlane M; Pritchard C; Moss E
    Gynecol Oncol; 2020 Jan; 156(1):251-259. PubMed ID: 31767187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug.
    Kalogera E; Roy D; Khurana A; Mondal S; Weaver AL; He X; Dowdy SC; Shridhar V
    Gynecol Oncol; 2017 Jul; 146(1):187-195. PubMed ID: 28545688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells
    Kuittinen T; Rovio P; Staff S; Luukkaala T; Kallioniemi A; Grénman S; Laurila M; Mäenpää J
    Anticancer Res; 2017 Dec; 37(12):6575-6581. PubMed ID: 29187432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies).
    Ono R; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Ishikawa M; Minamoto T; Razia S; Ishikawa N; Otsuki Y; Nakayama S; Onuma H; Kurioka H; Kyo S
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen gel droplet-embedded culture drug sensitivity test for adjuvant chemotherapy after complete resection of non-small-cell lung cancer.
    Inoue M; Maeda H; Takeuchi Y; Fukuhara K; Shintani Y; Funakoshi Y; Funaki S; Nojiri T; Kusu T; Kusumoto H; Kimura T; Okumura M;
    Surg Today; 2018 Apr; 48(4):380-387. PubMed ID: 28993901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination.
    De Guillebon E; Dardenne A; Saldmann A; Séguier S; Tran T; Paolini L; Lebbe C; Tartour E
    Int J Cancer; 2020 Sep; 147(6):1509-1518. PubMed ID: 31997345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.